{
  "docId": "019de074-753e-742e-8482-2e45ed67d022",
  "docSlug": "1014e5ae1361495c3b249a754ba0dfae",
  "documentTitle": "argenx SE | Investor Presentation Deck | 22 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 14,
  "pageCount": 22,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "key_messages",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a visual representation of an antibody structure to explain the 'sweeping' mechanism.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-753e-742e-8482-2e45ed67d022/14",
  "deckHref": "/decks/019de074-753e-742e-8482-2e45ed67d022",
  "deckJsonHref": "/decks/019de074-753e-742e-8482-2e45ed67d022.json",
  "deckAnchorHref": "/decks/019de074-753e-742e-8482-2e45ed67d022#slide-14",
  "components": [
    {
      "bbox": {
        "h": 0.3,
        "w": 0.15,
        "x": 0.83,
        "y": 0
      },
      "kind": "callout",
      "text": "clinical Broaden immunology pipeline",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5be52c89-0f02-4cf9-933c-64b1dfa82a15",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.25,
        "x": 0.05,
        "y": 0.4
      },
      "kind": "image",
      "text": "Antibody structure diagram showing pH/Ca2+ switch, optimal recycling, and no effector function.",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "41c6a119-534a-4676-baad-fb564529b577",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.6,
        "x": 0.35,
        "y": 0.35
      },
      "kind": "list",
      "text": "Indication selection starts with autoimmune diseases driven by classical and/or lectin pathway. Phase 2 proof-of-concept trial underway in multifocal motor neuropathy (MMN) with interim data expected in mid-2023. Phase 2 trials to start in delayed graft function and dermatomyositis.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5a165758-19ac-4eab-a2dc-fd4144b49f39",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.45,
        "x": 0.03,
        "y": 0.04
      },
      "kind": "title",
      "text": "ARGX-117: Targets C2 at Junction of Classical and Lectin Pathways",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "97a33939-ead9-496d-aa09-c5351ce6f9f7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "2x2 matrix",
      "slug": "matrix-2x2",
      "agent": null,
      "layer": "slide",
      "matchId": "f7897cc0-820a-43c9-9f84-51f3c9e7e2ea",
      "evidence": "Indication selection starts with autoimmune diseases driven by classical and/or lectin pathway",
      "confidence": 0.7
    },
    {
      "name": "AIDA Model",
      "slug": "aida-model",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "a0b83af6-f789-42cd-9302-49e45eddad10",
      "evidence": "Targets C2 at Junction of Classical and Lectin Pathways",
      "confidence": 0.5
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 17,
      "from": 10,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "7e79228a-9d20-4cb5-bd69-2e79252b8cfc",
      "evidence": "The presentation presents the company's solution and pipeline.",
      "position": 1,
      "objective": "The company's solution and pipeline as a big bet for growth",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}